OakChart

iTonic Holdings Ltd

ITOCHealthcare·Medical Devices·China·Nano·NASD·Nov 11 • 1:27 PM ET

1.83-0.18 (-8.96%)
2026-11-11 19:27 CET
Market cap
14.70 USD m
Revenue, TTM
0.56 USD m
Net income, TTM
-8.92 USD m
Free cash flow, TTM
-1.14 USD m
EPS diluted, TTM
-4.22
P/E
-
Compare

Price

ITOC against its 20, 50 and 200-day averages
2050200
5.0010.0015.001.1M2.1MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ITOCclose 1.8320-day 2.6950-day 3.81200-day 4.901.8352w high

90.1% under the 52-week high of 18.40 on 8 Jun 2026. 52-week low 1.63 on 6 Nov 2026. Last 15 sessions, 132.5% high to low

Profile

ITOC
52-week range, 1% of the way up
1.6318.40

iTonic Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

IPOSep 05, 2024
Beta3.16
ATR, 14d0.49
Rel volume1.36
Short float0.07%
Insider own17.46%
Inst own0.24%

Snapshot

6 groups

Valuation

Index-
Market Cap13.38M
Enterprise Value12.48M
Income-8.92M
Sales0.56M
Book/sh3.22
Cash/sh0.30
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees-
IPOSep 05, 2024

Ratios

P/E-
Forward P/E-
PEG-
P/S23.90
P/B0.57
P/C6.03
P/FCF-
EV/EBITDA-
EV/Sales22.29
Quick Ratio17.36
Current Ratio17.39
Debt/Eq0.01
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-4.22
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y-8.37% -7.12%
EPS Y/Y TTM-62.68%
Sales Y/Y TTM82.31%
EPS Q/Q39.89%
Sales Q/Q49.47%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own17.46%
Insider Trans0.00%
Inst Own0.24%
Inst Trans5.14%
ROA-56.27%
ROE-62.99%
ROIC-37.75%
Gross Margin33.25%
Oper. Margin-1471.55%
Profit Margin-1602.33%
SMA20-31.92%
SMA50-52.02%
SMA200-62.64%
Trades-

Technical

Shs Outstand6.84M
Shs Float6.04M
Short Float0.07%
Short Ratio0.07
Short Interest0.00M
52W High18.40 -90.05%
52W Low1.63 12.27%
Volatility20.37% 19.50%
ATR (14)0.49
RSI (14)30.31
Beta3.16
Rel Volume1.36
Avg Volume56.01K
Volume47,845

Performance

Perf Week-5.18%
Perf Month-53.55%
Perf Quarter-60.63%
Perf Half Y-63.12%
Perf YTD-72.82%
Perf Year-80.95%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom-
Target Price-
Prev Close2.01
Price1.83
Change %-8.96%

Peers

Mkt cap
TickerCompanyMkt cap
ARAYAccuray Inc10.03M
SRTSSensus Healthcare Inc55.14M
BDMDBaird Medical Investment Holdings Limited3.29M
CATXPerspective Therapeutics Inc99.40M
DRTSAlpha Tau Medical Ltd1.33B
NNOXNano X Imaging Ltd29.65M
CCMConcord Medical Services ADR10.12M
QTIQT Imaging Holdings Inc31.54M
AMSAmerican Shared Hospital Services7.98M
ICCMIcecure Medical Ltd2.71M

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual0.2120.093-0.266-0.831-5.086
Period20212022202320242025
EPS, quarterly
Period
Sales, annual0.7030.680.6290.4480.523
Period20212022202320242025
Sales, quarterly
Period
Shares, annual0.9060.9060.9060.8910.891
Period20212022202320242025
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Total Revenue0.560.520.450.630.680.70
Cost of Goods Sold Incl. D&A0.370.200.100.160.120.11
Gross Profit0.190.330.340.470.560.59
Selling, General and Administrative Excl. Other8.375.511.120.780.530.45
Research and Development0.990.460.090.080.070.08
Other Operating Expense0.000.000.000.000.000.00
Operating Income-8.19-5.19-0.77-0.310.030.14
Interest Expense-----0.00
Unusual Expense1.700.000.000.000.000.00
Net Income Before Taxes-9.84-5.10-0.64-0.260.070.20
Income Taxes0.000.000.02-0.02-0.010.01
Consolidated Net Income-9.84-5.10-0.66-0.240.080.19
Net Income From Continuing Operations-8.92-5.10-0.66-0.240.080.19
Net Income-8.92-5.10-0.66-0.240.080.19
EPS (Recurring)-1.72-5.09-0.83-0.270.090.21
EPS (Basic, Before Extraordinaries)-4.22-5.09-0.83-0.270.090.21
EPS (Diluted)-4.22-5.09-0.83-0.270.090.21
EBITDA-8.03-5.17-0.70-0.240.080.20
Non-Operating Income (Expense)0.040.090.130.050.040.07
Other After Tax Adjustments0.000.000.000.000.000.00
Stock Option Compensation Expense5.662.95----
Price To Sales Ratio38.8112.90125.17---
Gross Margin33.2562.5976.9674.9082.1184.06
Operating Margin-1,471.55-991.71-171.86-48.794.0519.65
Net Margin-1,602.33-974.68-147.39-38.3712.3527.39
Shares Outstanding7.320.890.890.910.910.91
Market Capitalization14.7014.701,005.48953.04--

Income statement, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S22023S12022S2
Total Revenue0.100.460.070.240.210.360.270.29
Cost of Goods Sold Incl. D&A0.190.180.010.040.030.090.070.07
Gross Profit-0.090.270.050.200.180.270.200.22
Selling, General and Administrative Excl. Other4.993.382.130.660.500.480.290.26
Research and Development0.570.420.040.050.050.050.040.05
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-5.08-3.11-2.08-0.46-0.31-0.21-0.09-0.03
Unusual Expense1.700.000.000.000.000.000.000.00
Net Income Before Taxes-6.78-3.06-2.04-0.34-0.30-0.17-0.09-0.00
Income Taxes0.000.000.000.04-0.02-0.02-0.00-0.01
Consolidated Net Income-6.78-3.06-2.04-0.38-0.29-0.16-0.080.01
Net Income From Continuing Operations-5.86-3.06-2.04-0.38-0.29-0.16-0.080.01
Net Income-5.86-3.06-2.04-0.38-0.29-0.16-0.080.01
EPS (Recurring)-1.04-2.91-2.17-0.42-0.31-0.17-0.090.01
EPS (Basic, Before Extraordinaries)-1.31-2.91-2.17-0.42-0.31-0.17-0.090.01
EPS (Diluted)-1.31-2.91-2.17-0.42-0.31-0.17-0.090.01
EBITDA-4.93-3.10-2.07---0.18-0.06-0.01
Non-Operating Income (Expense)-0.000.050.040.120.010.040.010.03
Stock Option Compensation Expense3.302.36------
Price To Sales Ratio38.8113.52904.27140.21----
Gross Margin-88.2060.1579.0383.9586.2875.1174.6276.33
Operating Margin-5,036.11-681.94-3,081.98-191.83-149.31-58.68-35.37-11.66
Net Margin-5,802.84-671.84-3,018.20-157.95-135.46-43.56-31.344.24
Shares Outstanding7.320.891.070.890.910.910.910.91
Market Capitalization14.7095.944,192.921,005.48953.04---

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY
Cash & Short Term Investments2.936.160.230.070.14
Short Term Receivables0.300.360.230.480.77
Inventories0.050.120.050.150.10
Other Current Assets0.810.040.020.020.01
Total Current Assets4.096.680.530.721.02
Net Property, Plant & Equipment0.040.050.220.220.30
Total Investments and Advances0.000.000.000.000.00
Intangible Assets4.370.000.000.000.00
Deferred Tax Assets-0.000.030.000.00
Other Assets0.600.000.850.460.02
Total Assets9.106.721.621.401.33
Short Term Debt Incl. Current Port. of LT Debt0.140.250.050.050.06
Accounts Payable0.070.010.020.010.02
Income Tax Payable---0.000.01
Other Current Liabilities0.250.281.140.620.04
Total Current Liabilities0.460.541.210.680.14
Long Term Debt0.000.000.100.170.24
Provision for Risks Charges0.000.000.000.000.00
Deferred Tax Liabilities0.510.000.01--
Other Liabilities0.000.000.000.000.00
Total Liabilities0.970.541.320.850.38
Non-Equity Reserves0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00
Common Equity6.126.180.310.560.95
Total Shareholders Equity6.126.180.310.560.95
Accumulated Minority Interest2.000.000.000.000.00
Total Equity8.136.180.310.560.95
Total Liabilities & Stockholders Equity9.106.721.621.401.33
Book Value Per Share6.876.940.340.611.05
Tangible Book Value Per Share1.976.940.340.611.05
Price to Book Ratio0.6263,000.0059,714.29--
Return on Assets-64.45-15.83-15.946.15-
Return on Equity-82.84-20.35-55.9311.12-
Return on Invested Capital-83.26-10.68-58.6511.6416.10
Quick Ratio8.7212.180.400.836.75
Current Ratio8.8312.400.441.067.48

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Net Income-9.84-5.10-0.66-0.240.080.19
Depreciation0.160.010.070.060.050.07
Other Funds (Non Cash)7.793.000.020.020.020.01
Funds from Operations-1.90-2.09-0.54-0.180.150.27
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.76-1.15-0.230.11-0.27-0.19
Income Taxes Payable---0.00-0.01-0.03
Cash from Operating Activities-1.14-3.24-0.78-0.06-0.120.08
Capital Expenditures-0.00-0.00-0.000.000.000.00
Net Assets From Acquisitions-20.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-0.00-1.400.000.000.000.00
Purchase of Investments-0.00-1.400.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.050.050.000.000.000.00
Cash from Investing Activities-19.95-1.35-0.000.000.000.00
Cash Dividends Paid0.000.000.000.00-0.400.00
Change in Capital Stock20.170.177.800.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock20.170.177.800.000.000.00
Proceedsfrom Stock Options20.170.177.800.000.000.00
Issuance or Reduction of Debt, Net-0.03-0.140.250.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.09-0.11-1.330.220.48-0.07
Other Financing Activities Uses-0.14-0.14-1.70-0.53-0.61-0.12
Cash from Financing Activities20.05-0.086.710.220.08-0.07
Exchange Rate Effect0.010.01-0.00-0.00-0.030.00
Net Change in Cash-1.03-4.675.930.16-0.060.01
Free Cash Flow-1.14-3.24-0.78-0.06-0.120.08
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.02-0.02-0.00-0.00

Balance sheet, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Cash & Short Term Investments2.222.933.216.160.030.23
Short Term Receivables0.470.300.190.360.190.23
Inventories0.050.050.130.120.040.05
Other Current Assets21.150.810.950.040.030.02
Total Current Assets23.884.094.476.680.290.53
Net Property, Plant & Equipment0.140.040.040.050.180.22
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets2.534.37-0.00-0.00
Deferred Tax Assets---0.000.040.03
Other Assets0.020.600.600.000.850.85
Total Assets26.589.105.116.721.361.62
Short Term Debt Incl. Current Port. of LT Debt0.200.140.140.250.300.05
Accounts Payable0.020.070.010.010.010.02
Other Current Liabilities1.150.250.230.280.961.14
Total Current Liabilities1.370.460.380.541.271.21
Long Term Debt0.040.000.000.000.070.10
Deferred Tax Liabilities0.510.51-0.00-0.01
Other Liabilities0.000.000.000.000.000.00
Total Liabilities1.920.970.380.541.351.32
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity23.576.124.736.180.020.31
Total Shareholders Equity23.576.124.736.180.020.31
Accumulated Minority Interest1.082.000.000.000.000.00
Total Equity24.658.134.736.180.020.31
Total Liabilities & Stockholders Equity26.589.105.116.721.361.62
Book Value Per Share3.226.874.446.940.020.34
Tangible Book Value Per Share2.881.974.446.940.020.34
Price to Book Ratio0.6224.26677.9663,000.0059,714.29-
Return on Assets-56.27-64.45-74.52-15.83-31.50-15.94
Return on Equity-62.99-82.84-101.64-20.35-188.15-55.93
Return on Invested Capital-24.79-49.98-43.06-6.07-315.74-38.33
Quick Ratio17.368.7211.3612.180.200.40
Current Ratio17.398.8311.6912.400.230.44

Cash flow, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Net Income-6.78-3.06-2.04---0.16
Depreciation0.150.010.01--0.03
Other Funds (Non Cash)5.442.350.65---0.00
Funds from Operations-1.19-0.71-1.38---0.15
Extraordinary Item0.000.000.00--0.00
Changes in Working Capital0.460.30-1.46--0.12
Income Taxes Payable-----0.00
Cash from Operating Activities-0.73-0.40-2.84---0.03
Capital Expenditures-0.00-0.00-0.00--0.00
Net Assets From Acquisitions-20.000.000.00--0.00
Sale of Fixed Assets and Businesses0.000.000.00--0.00
Purchase or Sale of Investments0.00-0.00-1.40--0.00
Purchase of Investments0.00-0.00-1.40--0.00
Sale Or Maturity of Investments0.000.000.00--0.00
Other Uses0.000.000.00--0.00
Other Sources0.000.050.00--0.00
Cash from Investing Activities-20.000.05-1.40--0.00
Cash Dividends Paid0.000.000.00--0.00
Preferred Dividends (Cash Flow)0.000.000.00--0.00
Change in Capital Stock20.000.170.00--0.00
Repurchase of Common Pref Stock0.000.000.00--0.00
Sale of Common Pref Stock20.000.170.00--0.00
Proceedsfrom Stock Options20.000.170.00--0.00
Issuance or Reduction of Debt, Net0.00-0.03-0.11--0.00
Change in Long Term Debt0.000.000.00--0.00
Issuance of Long Term Debt0.000.000.00--0.00
Reduction of Long Term Debt0.000.000.00--0.00
Net Financing Active Other Cash Flow0.02-0.110.00--0.23
Other Financing Activities Uses0.00-0.140.00---0.29
Cash from Financing Activities20.020.03-0.11--0.23
Exchange Rate Effect0.000.01-0.00---0.00
Net Change in Cash-0.71-0.32-4.35--0.19
Free Cash Flow-0.74-0.41-2.84---0.03

Revenue breakdown

Sales Of FTTPS2024: 369.55K 2025: 362.85K
Sales Of Medical Auxiliary Supplies2024: 78.65K 2025: 160.18K
China2024: 448.20K 2025: 523.03K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.07%0.0M6.0M54.28K
2026-10-150.17%0.0M6.0M52.38K
2026-09-300.01%0.0M96.6M49.58K
2026-09-150.07%0.0M6.0M40.12K
2026-08-311.27%0.0M0.5M78.09K
2026-08-141.23%0.0M0.5M74.06K
2026-07-311.80%0.0M0.5M52.96K
2026-07-151.60%0.0M0.5M102.13K
2026-06-301.37%0.0M0.5M101.39K
2026-06-150.98%0.0M0.5M239.77K
2026-05-292.39%0.0M0.5M203.51K
2026-05-153.60%0.0M0.5M203.34K
2026-04-304.15%0.0M0.5M206.51K
2026-04-151.93%0.0M0.5M162.84K
2026-03-314.14%0.0M0.5M238.12K
2026-03-130.09%0.0M0.5M83.22K
2026-02-270.08%0.0M0.5M83.01K
2026-02-130.27%0.0M0.5M83.45K
2026-01-300.19%0.0M0.5M84.12K
2025-12-310.21%0.0M0.5M6.62K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-02SEC
2026-09-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-09-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-10SEC
2026-08-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-27SEC
2026-08-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-26SEC
2026-06-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-23SEC
2026-05-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-13SEC
2026-04-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-23SEC
2026-04-073Initial statement of beneficial ownership of securities2024-09-06SEC
2026-04-0220-F/A2025-12-31SEC
2026-03-3020-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2025-12-31SEC
2026-03-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-24SEC
2026-03-163Initial statement of beneficial ownership of securities2024-09-06SEC
2026-03-163Initial statement of beneficial ownership of securities2024-09-06SEC
2026-02-23EFFECTEffectiveness filing by commission orderSEC
2026-02-20CORRESPSEC
2026-02-20CORRESPSEC
2026-02-20CORRESPSEC
2026-02-17UPLOADUpload SubmissionSEC
2026-02-06F-3Registration statement for specified transactions by certain foreign private issuersSEC
2026-01-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-26SEC
2026-01-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-13SEC
2025-12-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-22SEC
2025-12-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-06-30SEC
2025-12-116-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-11SEC
2025-12-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-05SEC
2025-11-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-11-28SEC
2025-11-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-11-26SEC
2025-11-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-11-10SEC
2025-10-216-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-10-21SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
XTX Topco Ltd0.45%
RENAISSANCE TECHNOLOGIES LLC0.26%
CITADEL ADVISORS LLC0.25%
Virtu Financial LLC0.23%
JANE STREET GROUP, LLC0.10%
StoneX Group Inc.0.06%
Point72 Asset Management, L.P.0.06%
Ground Swell Capital, LLC0.01%
NATIONAL BANK OF CANADA /FI/0.01%
UBS Group AG0.00%

Funds

Fund% owned
Fidelity Nasdaq Composite Index Fund0.04%

OakChart. ITOC. Cached 15 minutes.

Some panels did not load: ratings, insider, news.